title: Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Swiss HIV Cohort Study.
abstract: Discontinuation of primary prophylaxis against toxoplasma encephalitis was studied in 199 HIV-1-infected patients on antiretroviral combination treatment who had experienced a sustained increase in their CD4 count. During a follow-up of 272 person-years, no cases of toxoplasma encephalitis arose.
authors.forename: H
authors.initials: H
authors.lastname: Furrer
authors.forename: M
authors.initials: M
authors.lastname: Opravil
authors.forename: E
authors.initials: E
authors.lastname: Bernasconi
authors.forename: A
authors.initials: A
authors.lastname: Telenti
authors.forename: M
authors.initials: M
authors.lastname: Egger
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D018890:Chemoprevention; D015331:Cohort Studies; D016001:Confidence Intervals; D004660:Encephalitis / Q000469:parasitology* / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013557:Switzerland; D016781:Toxoplasmosis, Cerebral / Q000517:prevention & control*
chemical_list: D019380:Anti-HIV Agents; D000890:Anti-Infective Agents